Schedule of earnings per share |
The following table sets forth the calculation of basic and diluted net loss per share attributable to common stockholders during the three and nine months ended September 30, 2022 and 2021: | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended September 30, | | Nine Months Ended September 30, | | 2022 | | 2021 | | 2022 | | 2021 | Net loss attributable to Nuvve common stockholders | $ | (8,403,247) | | | $ | (6,976,580) | | | $ | (69,072,863) | | | $ | (18,525,606) | | Weighted-average shares used to compute net loss per share attributable to Nuvve common stockholders, basic and diluted | 21,952,882 | | | 18,627,978 | | | 19,972,016 | | | 15,931,466 | | Net Loss per share attributable to Nuvve common stockholders, basic and diluted | $ | (0.38) | | | $ | (0.37) | | | $ | (3.46) | | | $ | (1.16) | |
|
Schedule of antidilutive securities excluded from the computation of earnings per share |
The following outstanding shares of common stock equivalents were excluded from the calculation of the diluted net loss per share attributable to Nuvve common stockholders because their effect would have been anti-dilutive: | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended September 30, | | Nine Months Ended September 30, | | 2022 | | 2021 | | 2022 | | 2021 | Stock options issued and outstanding | 2,649,652 | | 2,890,564 | | | 2,624,818 | | 2,342,967 | | Nonvested restricted stock issued and outstanding | 1,117,868 | | 832,757 | | | 952,068 | | 667,297 | | Public warrants | 2,875,000 | | 2,875,000 | | | 2,875,000 | | 2,061,121 | | Private warrants | 136,250 | | 136,250 | | | 136,250 | | 97,679 | | PIPE warrants | 1,353,750 | | 1,353,750 | | | 1,353,750 | | 970,519 | | Stonepeak and Evolve warrants | 6,000,000 | | 6,000,000 | | | 6,000,000 | | 3,000,000 | | Stonepeak and Evolve options | 5,000,000 | | 5,000,000 | | | 5,000,000 | | 2,500,000 | | Institutional/Accredited Investor Pre-Funded Warrants | 869,674 | | | — | | | 293,077 | | | — | | Institutional/Accredited Investor Warrants | 2,739,130 | | | — | | | 923,077 | | | — | | | | | | | | | | Total | 22,741,324 | | 19,088,321 | | | 20,158,040 | | 11,639,583 | |
|